Assignee
FUTURE MEDICINE CO LTD
KR·5 granted patents·10 pending applications·5 citations·filing 2017–2024
Top patents by PatentIndex Score
15 records- 0181US11185556B2Pharmaceutical composition for preventing and treating glaucoma, containing adenosine derivativeFUTURE MEDICINE CO LTD·Filed 2018·Granted Nov 30, 2021·2 cites·4 claims
- 0276US11266644B2Pharmaceutical composition for preventing and treating diabetic nephropaphy including adenosine derivativeFUTURE MEDICINE CO LTD·Filed 2018·Granted Mar 8, 2022·3 cites·8 claims
- 0376US2024366651A1Pharmaceutical composition comprising adenosine derivative for prevention and treatment of retinal disease or optic nerve diseaseFUTURE MEDICINE CO LTD·Filed 2024·Application pending·0 cites
- 0473US12076334B2Pharmaceutical composition comprising adenosine derivative for prevention and treatment of retinal disease or optic nerve diseaseFUTURE MEDICINE CO LTD·Filed 2022·Granted Sep 3, 2024·0 cites·8 claims
- 0566US12083140B2Pharmaceutical composition for preventing and treating glaucoma, containing adenosine derivativeFUTURE MEDICINE CO LTD·Filed 2021·Granted Sep 10, 2024·0 cites·5 claims
- 0661US2022143029A1Pharmaceutical composition for preventing and treating nonalcoholic steatohepatitis, hepatic fibrosis, and liver cirrhosis, comprising adenosine derivativesFUTURE MEDICINE CO LTD·Filed 2022·Application pending·0 cites
- 0758US2022143017A1Pharmaceutical composition for preventing and treating diabetic nephropaphy including adenosine derivativeFUTURE MEDICINE CO LTD·Filed 2022·Application pending·0 cites
- 0858US2024300991A1Nucleoside derivative having multi-target kinase inhibitory activity and pharmaceutical composition for preventing and treating cancer comprising sameFUTURE MEDICINE CO LTD·Filed 2022·Application pending·0 cites
- 0957US11266650B2Pharmaceutical composition for preventing and treating nonalcoholic steatohepatitis, hepatic fibrosis, and liver cirrhosis, comprising adenosine derivativesFUTURE MEDICINE CO LTD·Filed 2017·Granted Mar 8, 2022·0 cites·2 claims
- 1057US2026027121A1Ligand acting on adenosine receptors and composition comprising same for prevention, alleviation, or treatment of obesitysFUTURE MEDICINE CO LTD·Filed 2023·Application pending·0 cites
- 1154US2024199679A1Adenosine derivative having antagonistic action on a2a and a3 adenosine receptors and method for preparing sameFUTURE MEDICINE CO LTD·Filed 2022·Application pending·0 cites
- 1253US2021361690A1Pharmaceutical composition comprising adenosine derivative for prevention and treatment of retinal disease or optic nerve diseaseFUTURE MEDICINE CO LTD·Filed 2018·Application pending·0 cites
- 1352US2024148769A1Pharmaceutical composition for preventing or treating coronavirus disease 19, containing carbocyclic nucleoside derivativeFUTURE MEDICINE CO LTD·Filed 2022·Application pending·0 cites
- 1448US2024325399A1Pharmaceutical composition for preventing or treating cholangitis or liver disease caused by cholangitis comprising adenosine derivativeFUTURE MEDICINE CO LTD·Filed 2022·Application pending·0 cites
- 1542US2024010987A1In vitro liver disease model using triple co-culture and preparation method thereofFUTURE MEDICINE CO LTD·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →